Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Biorem Inc. Regulatory Filings 2021

Mar 31, 2021

45371_rns_2021-03-31_41bf2e3a-e2ee-48f7-b82e-7282370dd4f7.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

FORM 13-501F1 CLASS 1 REPORTING ISSUERS AND CLASS 3B REPORTING ISSUERS – PARTICIPATION FEE

MANAGEMENT CERTIFICATION

==> picture [487 x 532] intentionally omitted <==

----- Start of picture text ----- I, ____________________ Douglas Newman , an officer of the reporting issuer noted below have examined thisForm 13-501F1 (the Form ) being submitted hereunder to the Alberta Securities Commission andcertify that to my knowledge, having exercised reasonable diligence, the information provided inthe Form is complete and accurate._________________________________ _________________________________ "Douglas Newman" March 31, 2021Name: Date: Douglas NewmanTitle: Chief Financial OfficerReporting Issuer Name: Biorem Inc.End date of previous financial year: December 31, 2020Type of Reporting Issuer: [ ] Class 1 reporting [ ] Class 3B reportingissuer issuerHighest Trading Marketplace: TSX VentureMarket value of listed or quoted equity securities:Equity Symbol BRM1st Specified Trading Period (dd/mm/yy) _______________ to ______________ January 1, 2020 March 31, 2020Closing price of the security in the class or series on thelast trading day of the specified trading period in whichsuch security was listed or quoted on the highest trading $ ______________________ 0.3100marketplace (i)----- End of picture text -----

Number of securities in the class or series of such
security outstanding at the end of the last trading day of ________________________38,661,558
the specified trading period (ii)
(i) x (ii) $ ______________________11,985,082.98
Market value of class or series (A)
2nd Specified Trading Period(dd/mm/yy) _______________ to ______________June 30, 2020April 1, 2020
Closing price of the security in the class or series on the
last trading day of the specified trading period in which
such security was listed or quoted on the highest trading $ ______________________0.3550
marketplace (iii)
Number of securities in the class or series of such
security outstanding at the end of the last trading day of ______________________38,661,558
the specified trading period (iv)
(iii) x (iv) $ ______________________13,724,853.09
Market value of class or series (B)
3rd Specified Trading Period(dd/mm/yy) _______________ to ______________September 30, 2020July 1, 2020
Closing price of the security in the class or series on the
last trading day of the specified trading period in which
such security was listed or quoted on the highest trading $ ______________________0.3450
marketplace (v)
Number of securities in the class or series of such
security outstanding at the end of the last trading day of ______________________38,661,558
the specified trading period (vi)
(v) x (vi) $ ______________________13,338,237.51
Market value of class or series (C)

==> picture [482 x 518] intentionally omitted <==

----- Start of picture text ----- 4th Specified Trading Period (dd/mm/yy) _______________ to ______________ October 1, 2020 December 31, 2020Closing price of the security in the class or series on thelast trading day of the specified trading period in whichsuch security was listed or quoted on the highest trading $ ______________________ 0.5400marketplace (vii)Number of securities in the class or series of suchsecurity outstanding at the end of the last trading day of ______________________ 38,661,558the specified trading period (viii)(vii) x (viii) $ ______________________ 20,877,241.32Market value of class or series (D)5th Specified Trading Period (dd/mm/yy) _______________ to ______________ N/A N/AClosing price of the security in the class or series on thelast trading day of the specified trading period in whichsuch security was listed or quoted on the highest trading $ ______________________marketplace (ix)Number of securities in the class or series of suchsecurity outstanding at the end of the last trading day of ______________________the specified trading period (x)(ix) x (x) $ ______________________Market value of class or series (E)Average Market Value of Class or Series (Calculatethe simple average of the market value of the class orseries of security for each applicable specified trading $ ______________________ 14,981,353.725period (i.e. A through E above)) ( 1 )----- End of picture text -----

(Repeat the above calculation for each other class or series of equity securities of the reporting issuer (and a subsidiary, if applicable) that was listed or quoted on a marketplace at the end of the previous financial year)

Fair value of outstanding debt securities:

(Provide details of how value was determined) $ ______________________0.0000
(2)
Capitalization for the previous financial year (1) + (2) $ ______________________14,981,353.725
Participation Fee $ ______________________500.0000
Late Fee, if applicable $ ______________________0.0000
Total Fee Payable $ ______________________500.0000
(Participation Fee plus Late Fee)